Catalyst Wire Dossier Catalyst Wire Dossier

Caplyta (lumateperone)

lumateperone · Intra-Cellular Therapies, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Caplyta (lumateperone), covering 2017-11-17 to 2025-05-20. Get the full timeline:

Most recent: Clinical Trial Update: Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia [Phase 4]

See pricing